KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Average Rating of “Moderate Buy” by Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been given an average rating of “Moderate Buy” by the six research firms that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and four have assigned a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $6.50.

KRMD has been the topic of a number of recent research reports. Wall Street Zen cut shares of KORU Medical Systems from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of KORU Medical Systems in a report on Thursday, January 22nd. B. Riley Financial upped their price target on KORU Medical Systems from $7.00 to $8.00 and gave the stock a “buy” rating in a research note on Friday, March 13th. Canaccord Genuity Group reaffirmed a “buy” rating and set a $6.00 price objective on shares of KORU Medical Systems in a research report on Friday, March 13th. Finally, Lake Street Capital lifted their price objective on KORU Medical Systems from $6.00 to $8.00 and gave the company a “buy” rating in a research note on Monday, December 22nd.

Hedge Funds Weigh In On KORU Medical Systems

Several large investors have recently modified their holdings of the stock. Cubist Systematic Strategies LLC grew its position in KORU Medical Systems by 927.4% during the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company’s stock valued at $196,000 after purchasing an additional 69,758 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in KORU Medical Systems by 189.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 242,781 shares of the company’s stock valued at $617,000 after purchasing an additional 158,914 shares in the last quarter. Jane Street Group LLC raised its holdings in KORU Medical Systems by 136.7% in the first quarter. Jane Street Group LLC now owns 163,137 shares of the company’s stock worth $414,000 after buying an additional 94,214 shares during the last quarter. Acadian Asset Management LLC purchased a new position in KORU Medical Systems in the first quarter worth about $63,000. Finally, Geode Capital Management LLC lifted its stake in shares of KORU Medical Systems by 101.3% in the second quarter. Geode Capital Management LLC now owns 997,147 shares of the company’s stock worth $3,571,000 after buying an additional 501,875 shares in the last quarter. Hedge funds and other institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Stock Up 1.2%

Shares of KRMD stock opened at $4.32 on Friday. The stock has a market cap of $200.32 million, a price-to-earnings ratio of -72.00 and a beta of 0.55. The business’s fifty day moving average is $4.73 and its 200 day moving average is $4.81. KORU Medical Systems has a twelve month low of $1.86 and a twelve month high of $6.61.

KORU Medical Systems (NASDAQ:KRMD) last announced its quarterly earnings data on Thursday, March 12th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.02) by $0.01. KORU Medical Systems had a negative return on equity of 15.90% and a negative net margin of 6.41%.The business had revenue of $10.90 million during the quarter, compared to analyst estimates of $10.90 million. Equities research analysts expect that KORU Medical Systems will post -0.13 earnings per share for the current fiscal year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.